مواقع التدريسيينجامعة الكوفة
abulfadhel jaber neamah alshaibani
Assistant Professor

abulfadhel jaber neamah alshaibani

0Publications
0Lectures

About

Abulfadhel jaber Neamah
Date of birth /Babylon /1987

Bachelor's degree in pharmacy science from college of pharmacy /kufa-university at 2010
Second student on my class in
Bachelor's degree
PhD. pharmaceutics from college of pharmacy /baghdad -university at 2025
Assist.Prof.Dr. in college of pharmacy /pharmaceutic department
Interest : Nanotechnology,dosage design
E-mail/
[email protected]
https://publons.com/researcher/1411835/abulfadhel-alshaibani

Orcid.org/0000-0002-4838-7027
Web of Science ResearcherID 
E-2722-2018

Publications

10
2024

Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery

AuthorsAbulfadhel J. Neamah Al-Shaibani, Mowafaq M. Ghareeb
Journalpharmacia
Date2024-05-29
Abstract

Abstract Olanzapine (OLZ) is classified as a typical antipsychotic drug utilized for the treatment of schizophrenia. Its oral bioavailability is 60% due to its low solubility and pre-systemic metabolism. Hence, the present work aims to formulate and evaluate OLZ nanoparticles dissolving microneedles (MNs) for transdermal delivery to overcome the problems associated with drug administration orally. OLZ nanoparticles were prepared by the nanoprecipitation method. The optimized OLZ nanoparticle formula was utilized for the fabrication of dissolving MNs by loading OLZ nanodispersion into polydimethylsiloxane (PDMS) micromould cavities, followed by casting the polymeric solution of polyvinylpyrrolidone(PVP-K30) and polyvinyl alcohol (PVA) to form MN matrix. The results revealed that the optimized OLZ nanoparticle formula (NP-5) exhibited particle size 115.76±5.45 nm, entrapment efficiency 78.4±5.46, and zeta potential -19.01±1.6 mV. The results of MNs revealed that MN-4 exhibits a high drug content of 98.52%, and ex vivo permeation through rabbit skin exhibited that MN-4 permeates more effectively than a simple patch by approximately 5.16 fold. In vivo pharmacokinetics study revealed that the area under curve AUC 0-∞ of MN-4 was 6054.56±376 ng. h/ml as compared with AUC0-∞ of marketed OLZ tablet was 3975.77±373 ng. h/ml. It can be concluded that the dissolving MN-4 patch is considered a promising formula to overcome the problems associated with drug administration orally and could improve drug bioavailability, in addition to the ease of administering the medication to schizophrenic patients.

2019

Rational Drug Use in Pediatric Wards of Al-Najaf with National and International Practices City: A Prescribing Audit and a Comparative Study

AuthorsAlridha Ali Mohammed Abd, Al-Gburi Karrar Mohammed Hasan1, Al-Shaibani Abulfadhel Jaber Neamah2, Abdulridha Taf Ali3, Muhsin Mustafa Haider3
JournalIndian Journal of Forensic Medicine & Toxicology
Abstract

In an attempt to prevent irrational prescribing and its associated ramifications which have been frequent particularly in pediatric patients, regular auditing of prescribing has gained rising interest. This study was conducted to evaluate medicine prescribing to pediatric patients in Al-Najaf city, Iraq. A cross-sectional study was conducted in pediatric wards of a teaching hospital in Al-Najaf city. 300 discharge prescriptions were collected by convenience sampling and analyzed according to the rational prescribing indicators recommended by the World Health Organization (WHO) for investigation of drug use in healthcare facilities. The mean of patients’ age was 1.94 year (±3.17, range=1 day to 14 years). Additionally, Pearson's chi-square (X2) and Fisher-exact tests were used to find if there was any association between the socio-demography and the study categorical variables. Results: There was no significant association between socio-demographic characteristics (age and gender) and study categorical variables (non-polypharmacy, injection and antibiotic prescribing). The average number of medications per single prescription was 3.54 (±1.16, range=1 to 8, n=1061). 94.33% was the study result for antibiotic prescriptions, 90.67% for injection prescriptions, 68.33% for generic prescribing and 51.18% for essential medicine list prescribing. The overall index of rational prescribing (IRP) was 2.18.

2019

DESIGN AND CHARACTERIZATION OF CANDESARTAN NANOEMULSION CONTAINING GARLIC OIL‏ CILEXETIL ORAL

AuthorsABULFADHEL JABER NEAMAH AL-SHAIBANIA, KARRAR MOHAMMED HASAN AL-GBURIB, KARRAR TALIB, KHUDHAIR ALBO HAMRAHA, ALI MOHAMMED ABD ALRIDHA
JournalInt J App Pharm
Abstract

الوصف Objective: This study was designed to prepare and characterize oil in water (o/w) nanoemulsion of candesartan cilexetil for oral administration. Preparation of candesartan cilexetil as nanoemulsion could increase its water solubility and thus could enhance its bioavailability. Methods: Aqueous titration method was used to construct the pseudo-ternary phase diagrams of nanoemulsion (NE) consisting of oil, various weight ratios of surfactant and co-surfactant (S mix), and deionized water. Different characterization techniques were conducted on the prepared nanoemulsions to obtain the optimized formula. Results: Characterizations of formula NE-4 (consists of 0.16% of candesartan cilexetil, 10% of garlic oil, 35% of S mix (3: 1) and 54.84% of deionized water) revealed the following characteristics: droplet size range (95-139 nm), polydispersity index (0.14), zeta potential value (-41.06 mV) and pH value (6.71), which are suitable for oral administration. Candesartan cilexetil in vitro release from this formula was significantly high (P< 0.05) and scanning probe microscopy (SPM) study confirmed that the optimized formula (NE-4) was in nano-scale. Conclusion: Nanoemulsion formula 4 (NE-4) of candesartan cilexetil is the optimized formula and it could be a promising formula for improving the water solubility of candesartan cilaxetil.

2019

Evaluation of Prescribing Practice at Secondary Care Units in Annajaf Governorate, Iraq

AuthorsAlridha Ali Mohammed Abd, Assad Hayder Chassib1, Al-Gburi Karrar Mohammed Hasan1, Al-Shaibani Abulfadhel Jaber Neamah1, Hamrah Karrar Talib Khudair Albo1
JournalIndian Journal of Forensic Medicine & Toxicology
Abstract

Rational drug prescribing has been proven fundamental to upgrade the quality of healthcare services. Examining the existing practice is essential to develop a better understanding of the successful encounters and to identify the areas of challenges where a counter plan can be directed. The aim of this work is to evaluate the prescribing practice in Annajaf Governorate, Iraq. A descriptive cross-sectional study was conducted in three government hospitals. 404 discharge prescriptions (23 medications) were collected and analyzed according to the WHO model of rational prescribing. Index of rational medicine prescribing (IRMP) was used as an overall indicator of rational prescribing. The main finding was that the percentage values (% ± standard deviation) of prescribing indicators were substandard for antibiotic prescribing (83.91% ± 0.37 vs. ≤30%), generic prescribing (37.82% ± 2.17 vs. 100%), injection prescribing (63.43% ± 3.64 vs. ≤ 10%), and essential drug list prescribing (67.18% ± 2.09 vs. 100%). Additionally, the number of drugs per prescription was 5.73 ± 2.27 vs. an optimal value of ≤ 2. The IRMP was 1.92 (vs 5 for optimal prescribing).

2014

A Comparative Study Between the Effect of Hydrochlorothiazide and Furosemide on the Anticoagulant Activity of Warfarin

Authors Abulfadhel J. Neamah; , Mohammed D. AL-Yousuf; Mohammed Ali M. Younis; Nadhim K. Hante;
JournalIraq
Abstract

Keywords : warfarin, the effect of furosemide on warfarin activity , the effect of hydrochlothiazide on warfarin activity, furosemide , hydrochlothiazide (Received :June 2013, Accept : Jun 2014) Abstract Background:It has been widely reported that diuretics therapy affect serum calcium level which is in turn may affect the coagulation pathways and thereby could affect the activity of anticoagulation therapy. This study was undertaken to evaluate the effect of simultaneous diuretic intake on the anticoagulant activity of warfarin. Patients and Method: Twenty patients enrolled in this study divided to two groups, group 1 ( N=10 patients) were taking furosemide 80mg/day plus warfarin 3 mg /day. Group 2 (N=10 patients) were taking hydrochlorothiazide 50 mg /day plus warfarin 3 mg/day. Blood samples were taken from each patient and used for measurement of serum calcium level, prothrombine time(PT) and international normalized ratio(INR). Results: It has been found that there was a significant reduction (P<0.01) in calcium concentration in patients taking furosemide with warfarin (group 1) with respect to those who were taking hydrochlothiazide in addition to warfarin(group 2). On the other hand both PT and INR weresignificantly increased in patients with group 1 with respect to those in group 2. Conclusions:It may be concluded from this study that the combination of hydrochlorothiazide with warfarin may decrease the anticoagulant activity of the later.

1/2/2017

FORMULATION AND CHARACTERIZATION OF NIMODIPINE NANOEMULSION AS AMPOULE FOR ORAL ROUTE

Authors Abulfadhel J. Neamah, Mowafaq M. Ghareeb
JournalIndia
Abstract

ABSTRACT: The aim of this study was to develop oil in water nanoemulsion of nimodipine intended for oral use. Nimodipine is a calcium channel blocker that has poor oral bioavailability (3-30%) due to its low solubility and first- pass metabolism. So, nanoemulsion of nimodipine increase its solubility and enhance its oral bioavailability. Pseudo -ternary phase diagrams were made by using aqueous titration method. Nanoemulsions of pseudo-ternary phase diagrams composed of S mix (mixture of surfactant and co- surfactant), oil and deionized water. These nanoemulsions subjected for thermodynamic stability tests in order to select optimized formulations. Nimodipine nanoemulsions were subjected for characterizations studies in order to select the optimized formula. The characterizations studies explain that the optimized formula NE5 composed of 0.6% of nimodipine, 25% of S mix (2:1) that mean (16.66% tween 20: 8.33% PEG400), 10% of oleic acid and 64.4% of deionized water. The optimized formula NE5 characterized by droplet size (50 – 81.2 nm), polydispersity index (0.01), pH value (6.51), higher zeta potential (- 45.6 mV), drug content (98.9%), low viscosity and in vitro release of nimodipine was significantly higher (P<0.05) for NE5. Scanning probe microscopy (SPM) study confirms that the droplet size of NE5 was in nanoscale. It can be concluded that the optimized formula (nimodipine NE5) was a promising formula of nanoemulsion to enhance the oral bioavailability of nimodipine.

QUALITY CONTROL TESTING OF CONVENTIONAL CLOPIDOGREL BISULFATE TABLETS MARKETED IN IRAQ

AuthorsMAZIN THAMIR ABDUL-HASAN, ABULFADHEL JABER NEAMAH Al-SHAIBANI1, ALI N. WANNAS1, KARRAR MOHAMMED HASAN AL-GBURI2
Journalinterbational journal of applied pharmaceutics
Abstract

ABSTRACT Objective: This study was employed to evaluate the quality of marketed oral tablets containing clopidogrel bisulfate. Tablets produced by various companies and commercialized in the Iraq market were used in the study. Methods: Batches of clopidogrel bisulfate conventional tablets (containing 75 mg of drug) were exposed to the quality control tests. These tests involved friability, weight variation, hardness, drug content, disintegration time, and in vitro release study; these tests were conducted depending on USP pharmacopeia. Results: The data indicate that all batches of clopidogrel bisulfate complied with the limitations of USP pharmacopeia for variation of weight, results of the hardness of tablets were 7.2-9.6 Kg/cm2. Friability value (% loss) was less than one, which was within the required limits. The time of disintegration was less than 25 min in both artificial gastric fluid (AGF) and artificial intestinal fluid (AIF). Drug content was observed between 97.1 % and 99.8 %, indicating compliance with the limits of pharmacopeia (85-115 %). An in vitro release study of batches was greater than 80 % within 25 min. Conclusion: All batches of clopidogrel bisulfate were manufactured within the criteria of tablet manufacturing. The quality control tests of tablets showed acceptable pharmaceutical properties (effectiveness and safety) that lie within the limits of USP pharmacopeia. Keywords: Oral tablets, Clopidogrel bisulfate, Biopharmaceutics classification system (BCS) solubility

QUALITY CONTROL TESTING OF CONVENTIONAL CLOPIDOGREL BISULFATE TABLETS MARKETED IN IRAQ

AuthorsMAZIN THAMIR ABDUL-HASAN, ABULFADHEL JABER NEAMAH Al-SHAIBANI1, ALI N. WANNAS1, KARRAR MOHAMMED HASAN AL-GBURI2
Journalinterbational journal of applied pharmaceutics
Abstract

ABSTRACT Objective: This study was employed to evaluate the quality of marketed oral tablets containing clopidogrel bisulfate. Tablets produced by various companies and commercialized in the Iraq market were used in the study. Methods: Batches of clopidogrel bisulfate conventional tablets (containing 75 mg of drug) were exposed to the quality control tests. These tests involved friability, weight variation, hardness, drug content, disintegration time, and in vitro release study; these tests were conducted depending on USP pharmacopeia. Results: The data indicate that all batches of clopidogrel bisulfate complied with the limitations of USP pharmacopeia for variation of weight, results of the hardness of tablets were 7.2-9.6 Kg/cm2. Friability value (% loss) was less than one, which was within the required limits. The time of disintegration was less than 25 min in both artificial gastric fluid (AGF) and artificial intestinal fluid (AIF). Drug content was observed between 97.1 % and 99.8 %, indicating compliance with the limits of pharmacopeia (85-115 %). An in vitro release study of batches was greater than 80 % within 25 min. Conclusion: All batches of clopidogrel bisulfate were manufactured within the criteria of tablet manufacturing. The quality control tests of tablets showed acceptable pharmaceutical properties (effectiveness and safety) that lie within the limits of USP pharmacopeia. Keywords: Oral tablets, Clopidogrel bisulfate, Biopharmaceutics classification system (BCS) solubility

PREPARATION AND OPTIMIZATION OF CILOSTAZOL NANOEMULSION ORAL LIQUID DOSAGE FORM

AuthorsABULFADHEL JABER NEAMAH AL-SHAIBANI, KARRAR AL-GBURI2*, KARRAR TALIB KHUDHAIR ALBO HAMRAH3
Journalinternational journal of applied pharmaceutics
Abstract

ABSTRACT Objective: Cilostazol has poor water solubility and low oral bioavailability. Therefore, the formulation of cilostazol as a nanoemulsion may enhance its solubility and improve oral bioavailability. Hence, the aim of this study was to formulate and characterize an oil-in-water (o/w) nanoemulsion of cilostazol as an oral liquid dosage form. Methods: Pseudo-ternary phase diagrams were constructed using the aqueous titration method. Formulations of pseudo-ternary phase plots consisting of oil, various weight ratios of S mix (mixture of surfactant and co-surfactant), and deionized water were made. Different characterization studies, droplet size measurement, polydispersity index, drug content, zeta potential measurement, and in vitro release have been conducted to choose the optimized formula. Results: The characterization studies have demonstrated that the optimized formula is (F-6), consisting of 20 % S mix (3:1), 10% ginger oil, and 70% deionized water. This formula had the following characteristics; droplet size (72.9-110 nm), polydispersity index (0.22), percentage of drug content (99.8%), and in vitro release of cilostazol nanoemulsion was significantly higher (P<0.05) in comparison with other formulations. A Scanning probe microscopy (SPM) study has revealed that the droplet size of F-6 was at the nano-scale. Conclusion: In conclusion, the optimized cilostazol formula (F-6) is a promising formula which may have the capability of improving the oral bioavailability of cilostazol. Keywords: Nanoemulsion, Pseudo-ternary phase diagram, Solubility, Cilostazol

Ionic liquid: A green designer solvent for topical delivery of Nano system

AuthorsAbulfadhel jaber neamah, Mowafaq M. Ghareeb Department of Pharmaceutics, College of Pharmacy, Baghdad University, Baghdad, Iraq. Asmaa M. Rashid Department of Pharmaceutics, College of Pharmacy, Baghdad University, Baghdad, Iraq.
JournalMaaen Journal for Medical Sciences
Abstract

Abstract Ionic liquids (ILs) defined as organic salts that produced from combination of organic cation with various types of organic/inorganic anions whose melting point less than 100 C. Because of their ionic character, most of ionic liquids exhibit useful properties such as no volatility, recyclability, good thermal stability, high conductivity and chemical stability. Ionic liquid cationeanion combinations permits the solvents to be prepared such as N, N-dialkylimidazolium as cation and acetate as anion. Ionic liquid was utilized as solvents or preparation components in various areas of drug delivery systems, also as novel liquid forms of APIs in various stages of design drug delivery systems. Also their incorporation with polymers has enabled the development of drug delivery systems for new therapeutic routes of administration. Recently ionic liquid can be used as solubility and permeability enhancer to deliver drugs with poor aqueous solubility and low lipophilicity by designing topical drug delivery of nano system.

Lectures

13
View details